eural mechanism of impulse control on addiction by tDCS and a cognitive neuroscience approach
Phase 3
Recruiting
- Conditions
- A treatment option for substance dependence
- Registration Number
- JPRN-UMIN000016163
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
the ones who suffer from the severe medical (i.e.: arrhythmia) or brain-injury disease (i.e.: histories ofneurostimulator implantation stroke, epilepsy, brain tumor, brain infection, brain hemorrhage, brain pressure elevation); pregnant woman; neuro-device implantation; Pacemaker; Surgical intervention of brain.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BZD dependence self report questionnaire for craving of Zolpidem; Fagerstrom Test for Nicotine Dependence (FTND) for Nicotine dependence; Visual analogue scale (VAS);Depression and somatic symptoms scale (DSSS);
- Secondary Outcome Measures
Name Time Method erocognitive testings will be also performed three times, baseline, Day 5 and 2 weeks post-treatment Go/no-go back; CANTAB